SCHEMBL1148944

SCHEMBL1148944

CC1NC(C(=O)O)CS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4223232 1.00 — —
SCHEMBL30548405 1.00 — —
SCHEMBL2033245 1.00 — —
SCHEMBL29957398 1.00 — —
SCHEMBL2033246 1.00 — —
SCHEMBL8231312 1.00 — —
SCHEMBL3829757 1.00 — —
SCHEMBL10107765 0.82 — —
SCHEMBL18760017 0.80 — —
SCHEMBL11358106 0.78 KMT2A (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937710-B1 KININ B1 RECEPTOR PEPTIDE AGONISTS AND USES THEREOF SOCPRA SCIENCES SANTE ET HUMAINES S E C (CA) 2012-10-17 — — EP claimed
US-20120129774-A1 KININ B1 RECEPTOR PEPTIDE AGONISTS AND USES THEREOF UNIVERSITE DE SHERBROOKE (CA) 2012-05-24 — — US claimed
US-8076453-B2 Kinin B1 receptor peptide agonists and uses thereof Societe De Commercialisation Des Produits De La Recheche Appliquee-Socpra-Science Sante Et Humaines S.E.C. (CA) 2011-12-13 — — US claimed
US-20090054347-A1 KININ B1 RECEPTOR PEPTIDE AGONISTS AND USES THEREOF UNIVERSITE DE SHERBROOKE (CA) 2009-02-26 — — US claimed
EP-1937710-A1 KININ B1 RECEPTOR PEPTIDE AGONISTS AND USES THEREOF Université de Sherbrooke (CA) 2008-07-02 — — EP claimed
WO-2008008380-A1 COMBINATION THERAPY FOR ADDICTION DISORDERS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2008-01-17 — — WO claimed
WO-2006128293-A1 KININ B1 RECEPTOR PEPTIDE AGONISTS AND USES THEREOF UNIVERSITé DE SHERBROOKE (CA) 2006-12-07 — — WO claimed
EP-0198898-B1 DIPEPTIDE COMPOUNDS HAVING PHARMACEUTICAL ACTIVITY AND COMPOSITIONS CONTAINING THEM ZAMBON S.p.A. (IT) 1988-08-24 — — EP claimed
CN-120149553-A Non-corrosive electrolyte solvent, electrolyte and battery 上海交通大学 2025-06-13 — — CN disclosed
CN-119954739-A Compound, preparation method thereof, pharmaceutical composition and application 宁波友波生物科技有限公司 2025-05-09 — — CN disclosed
US-20250114317-A1 Use of L-cysteine for improving the structure and function of gastric mucosa BIOHIT OYJ (FI) 2025-04-10 — — US disclosed
US-20250042931-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS Azura Ophthalmics Ltd. (IL) 2025-02-06 — — US disclosed
EP-4456982-A1 USE OF L-CYSTEINE FOR IMPROVING THE STRUCTURE AND FUNCTION OF GASTRIC MUCOSA BIOHIT OYJ (FI) 2024-11-06 — — EP disclosed
CN-118804657-A Method for constructing targeting molecular bridge to improve efficiency and stability of all-inorganic perovskite solar cell 陕西师范大学 2024-10-18 — — CN disclosed
US-4374249-A HYPOTENSIVE AGENTS AMERICAN CYANAMID COMPANY (US) 1983-02-15 — — US disclosed
US-4282235-A Derivatives of thiazolidinecarboxylic acids and related acids E. R. SQUIBB & SONS, INC. (US) 1981-08-04 — — US disclosed
US-4237129-A Derivatives of thiazolidinecarboxylic acids and related acids E. R. SQUIBB & SONS, INC. (US) 1980-12-02 — — US disclosed
US-4237134-A ANGIOTENSIN CONVERTING ENZYME INHIBITORS E. R. SQUIBB & SONS, INC. (US) 1980-12-02 — — US disclosed
EP-0012401-A1 Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them MERCK & CO. INC. (US) 1980-06-25 — — EP disclosed
US-4192878-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1980-03-11 — — US disclosed
Send feedback